{"id":49710,"date":"2025-12-02T12:35:11","date_gmt":"2025-12-02T04:35:11","guid":{"rendered":"https:\/\/flcube.com\/?p=49710"},"modified":"2025-12-02T12:35:12","modified_gmt":"2025-12-02T04:35:12","slug":"chempartner-and-fosun-pharma-forge-cro-cdmo-alliance-to-accelerate-drug-development","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=49710","title":{"rendered":"ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development"},"content":{"rendered":"\n<p><strong>Shanghai ChemPartner Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/300149:SHE\">SHE: 300149<\/a>) and <strong>Fosun Pharmaceutical (Group) Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/600196:SHA\">SHA: 600196<\/a>, <a href=\"https:\/\/www.google.com\/finance\/quote\/2196:HKG\">HKG: 2196<\/a>) announced a <strong>strategic cooperation framework agreement<\/strong> to integrate ChemPartner\u2019s full\u2011spectrum CRO\/CDMO capabilities with Fosun\u2019s innovation pipeline, streamlining key drug development processes.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-deal-overview\">Deal Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Element<\/th><th>Details<\/th><\/tr><\/thead><tbody><tr><td><strong>Companies<\/strong><\/td><td>ChemPartner + Fosun Pharma<\/td><\/tr><tr><td><strong>Agreement Type<\/strong><\/td><td>Strategic cooperation framework<\/td><\/tr><tr><td><strong>Date Signed<\/strong><\/td><td>25\u202fNov\u202f2025<\/td><\/tr><tr><td><strong>Focus<\/strong><\/td><td>End\u2011to\u2011end drug development efficiency<\/td><\/tr><tr><td><strong>Geography<\/strong><\/td><td>China\u2011centric with global ambitions<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-chempartner-s-service-platform\">ChemPartner\u2019s Service Platform<\/h2>\n\n\n\n<p><strong>Leading domestic CRO &amp; CDMO<\/strong> covering:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Biologics<\/strong>: Early\u2011stage antibody discovery, pharmacology\/efficacy, PK, early toxicology<\/li>\n\n\n\n<li><strong>Small Molecules<\/strong>: Chemistry R&amp;D, process development, manufacturing<\/li>\n\n\n\n<li><strong>New Modalities<\/strong>: XDC, Peptides, Oligonucleotides, PROTACs<\/li>\n\n\n\n<li><strong>One\u2011Stop Model<\/strong>: Integrated services from target to clinical supply<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-fosun-pharma-s-innovation-engine\">Fosun Pharma\u2019s Innovation Engine<\/h2>\n\n\n\n<p><strong>Therapeutic Areas<\/strong>: Oncology, immuno\u2011inflammation, chronic diseases (cardiovascular, renal, metabolic), CNS disorders<br><strong>Technology Platforms<\/strong>: Antibody\/ADC, Cell Therapy, Small Molecules<br><strong>Strategic Positioning<\/strong>: Radiopharmaceuticals, RNA, Gene Therapy, AI drug discovery<br><strong>Pipeline Depth<\/strong>: Significant project reserves across Class\u202f1 innovations<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale-amp-market-context\">Strategic Rationale &amp; Market Context<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Synergy<\/strong>: ChemPartner\u2019s service breadth matches Fosun\u2019s diversified R&amp;D needs<\/li>\n\n\n\n<li><strong>Speed &amp; Quality<\/strong>: One\u2011stop model reduces handoff friction, accelerates timelines<\/li>\n\n\n\n<li><strong>Market Growth<\/strong>: China\u2019s biotech CRO sector expanding at <strong>>20\u202f% CAGR<\/strong><\/li>\n\n\n\n<li><strong>Competitive Moat<\/strong>: Vertically integrated partnership creates end\u2011to\u2011end innovation engine<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding partnership execution and development milestones. Actual outcomes may differ due to regulatory, competitive, and operational risks.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shanghai ChemPartner Co., Ltd. (SHE: 300149) and Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG:&#8230;<\/p>\n","protected":false},"author":1,"featured_media":49712,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[214,19,159,893,892,1020],"class_list":["post-49710","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-chempartner-pharmatech","tag-cro-cmo-cdmo","tag-fosun-pharmaceutical","tag-hkg-2196","tag-sha-600196","tag-she-300149"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Shanghai ChemPartner Co., Ltd. (SHE: 300149) and Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG: 2196) announced a strategic cooperation framework agreement to integrate ChemPartner\u2019s full\u2011spectrum CRO\/CDMO capabilities with Fosun\u2019s innovation pipeline, streamlining key drug development processes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=49710\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development\" \/>\n<meta property=\"og:description\" content=\"Shanghai ChemPartner Co., Ltd. (SHE: 300149) and Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG: 2196) announced a strategic cooperation framework agreement to integrate ChemPartner\u2019s full\u2011spectrum CRO\/CDMO capabilities with Fosun\u2019s innovation pipeline, streamlining key drug development processes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=49710\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-02T04:35:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-02T04:35:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0201.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49710#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49710\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development\",\"datePublished\":\"2025-12-02T04:35:11+00:00\",\"dateModified\":\"2025-12-02T04:35:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49710\"},\"wordCount\":245,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49710#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/0201.webp\",\"keywords\":[\"ChemPartner Pharmatech\",\"CRO \\\/ CMO \\\/ CDMO\",\"Fosun Pharmaceutical\",\"HKG: 2196\",\"SHA: 600196\",\"SHE: 300149\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=49710#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49710\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=49710\",\"name\":\"ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49710#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49710#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/0201.webp\",\"datePublished\":\"2025-12-02T04:35:11+00:00\",\"dateModified\":\"2025-12-02T04:35:12+00:00\",\"description\":\"Shanghai ChemPartner Co., Ltd. (SHE: 300149) and Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG: 2196) announced a strategic cooperation framework agreement to integrate ChemPartner\u2019s full\u2011spectrum CRO\\\/CDMO capabilities with Fosun\u2019s innovation pipeline, streamlining key drug development processes.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49710#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=49710\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49710#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/0201.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/0201.webp\",\"width\":1080,\"height\":608,\"caption\":\"ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=49710#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development - Insight, China&#039;s Pharmaceutical Industry","description":"Shanghai ChemPartner Co., Ltd. (SHE: 300149) and Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG: 2196) announced a strategic cooperation framework agreement to integrate ChemPartner\u2019s full\u2011spectrum CRO\/CDMO capabilities with Fosun\u2019s innovation pipeline, streamlining key drug development processes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=49710","og_locale":"en_US","og_type":"article","og_title":"ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development","og_description":"Shanghai ChemPartner Co., Ltd. (SHE: 300149) and Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG: 2196) announced a strategic cooperation framework agreement to integrate ChemPartner\u2019s full\u2011spectrum CRO\/CDMO capabilities with Fosun\u2019s innovation pipeline, streamlining key drug development processes.","og_url":"https:\/\/flcube.com\/?p=49710","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-12-02T04:35:11+00:00","article_modified_time":"2025-12-02T04:35:12+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0201.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=49710#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=49710"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development","datePublished":"2025-12-02T04:35:11+00:00","dateModified":"2025-12-02T04:35:12+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=49710"},"wordCount":245,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=49710#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0201.webp","keywords":["ChemPartner Pharmatech","CRO \/ CMO \/ CDMO","Fosun Pharmaceutical","HKG: 2196","SHA: 600196","SHE: 300149"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=49710#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=49710","url":"https:\/\/flcube.com\/?p=49710","name":"ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=49710#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=49710#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0201.webp","datePublished":"2025-12-02T04:35:11+00:00","dateModified":"2025-12-02T04:35:12+00:00","description":"Shanghai ChemPartner Co., Ltd. (SHE: 300149) and Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG: 2196) announced a strategic cooperation framework agreement to integrate ChemPartner\u2019s full\u2011spectrum CRO\/CDMO capabilities with Fosun\u2019s innovation pipeline, streamlining key drug development processes.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=49710#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=49710"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=49710#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0201.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0201.webp","width":1080,"height":608,"caption":"ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=49710#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"ChemPartner and Fosun Pharma Forge CRO-CDMO Alliance to Accelerate Drug Development"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/12\/0201.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=49710"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49710\/revisions"}],"predecessor-version":[{"id":49714,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/49710\/revisions\/49714"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/49712"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=49710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=49710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=49710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}